Purchase Order AG52KJP170005
- Not listed
- The U.S. government awarded a $78,336 firm fixed-price purchase order to Illumina, Inc. on September 26, 2019, for genomic sequencing consumables. The contract, issued by a civilian federal agency's Northeast Area office, requires delivery of a BeadChip ABT 6000 Infinium HD i-Select-24 kit (catalog number WG-401-1001) capable of processing 48 samples with 3072-90K resolution to Illumina's San Diego, California facility by October 26, 2019. The procurement did not utilize a set-aside designation,...
- This is a $13,708.80 firm fixed price delivery order contract awarded by the U.S. Department of Agriculture's (USDA) Pacific West Area to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the procurement of ISELECT 24x1 HTS Custom DNA Analysis Kits, which include Illumina's proprietary BeadChip sequencing platform and associated reagents. This contract does not have a set-aside designation. Illumina has been awarded numerous prime...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing technologies, was awarded a $35,052.16 firm fixed price call under a Blanket Purchase Agreement (BPA) on December 15, 2015, for NextEra XT DNA Sample Kits. This contract, which carried no set-aside designation, reflected Illumina's specialized capabilities in providing advanced genomic sequencing consumables and reagents. The award was funded by a civilian federal agency (Plains Area) with a completion...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The $47,945.52 contract is for kitted reagents to prepare DNA sequencing libraries and complete four instrument runs using Illumina's HiSeq2000 DNA sequencer, generating 200 base pairs of sequence data per molecule. The award is not associated with a set-aside designation or a larger federal contract vehicle. Illumina has been awarded...
- The U.S. government awarded a $12,055.68 firm fixed-price purchase order to Illumina, Inc. for an HiSeq SBS V4 Kit (50 Cycle) on June 14, 2018, with a completion date of June 22, 2018. The award was issued by a civilian federal agency within the Midwest Area and does not utilize a set-aside designation. The place of performance is Illumina's headquarters location in San Diego, California. This contract represents a procurement of specialized sequencing reagent consumables from Illumina, a...
- The U.S. government awarded a $17,971.20 firm fixed-price purchase order to Illumina, Inc. for an Infinium HD Select-24 Kit containing 48 samples and 2 custom BeadChips. The contract was executed on August 15, 2018, with an ultimate completion date of September 14, 2018, and performance conducted at Illumina's San Diego, California location. No set-aside designation was applied to this award, reflecting the specialized nature of the genomic sequencing technology being procured. The funding...
- This is a $14,976 firm fixed-price purchase order contract awarded by the Plains Area agency of the U.S. government to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for the provision of a 50K INFINIUM HTS ISELECT-24 KIT and has an ultimate completion date of May 31, 2020. The contract does not utilize any set-aside designations. Illumina holds two significant federal Indefinite Delivery Vehicles (IDVs) with the...
- Illumina, Inc., a leading biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Blanket Purchase Agreement (BPA) call valued at $24,742.85 for genetic analysis products by a civilian federal agency within the Southeast Area on July 6, 2016. The contract, which represents a firm fixed-price arrangement with no set-aside designation, was completed by August 5, 2016, and performed at Illumina's San Diego, California headquarters. This award reflects the...
- This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
- This federal contract award is for the delivery of DNA/RNA reagent kits for sequencing, with a ceiling value of $174,029.49 and a completion date of January 30, 2026. The contract was awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The funding federal agency is the Northeast Area, a civilian agency. Illumina has been awarded multiple federal contracts...
The U.S. government awarded a $4,992 firm fixed-price purchase order to Illumina, Inc. for a 6K DNA Analysis Kit on December 30, 2016, with completion targeted for March 31, 2017. The contract was issued by a civilian federal agency operating under the Midwest Area designation and will be performed at Illumina's facility in San Diego, California. This award carries no set-aside designation, reflecting the specialized and competitive nature of Illumina's genomic sequencing technologies in the federal marketplace. Illumina, a leading biotechnology company specializing in genetic sequencing and genomic analysis, provides critical DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to multiple federal agencies. The company's extensive federal contracting history spans agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, Department of Veterans Affairs, and the Food and Drug Administration. Beyond individual purchase orders, Illumina maintains a $45 million Indefinite Delivery Contract with the U.S. Department of Agriculture running through June 2030, demonstrating the government's reliance on the company's advanced sequencing platforms for research applications across infectious disease, agricultural genetics, and environmental monitoring initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/30/16 |